Advancing regenerative medicine in the US requires regulatory change
This article was originally published in RAJ Devices
Executive Summary
Americans have been engaged in a detailed and politically charged debate about healthcare reform for the past few years, but there has been surprisingly little discussion about ways new technologies such as regenerative medicine can improve clinical care and reduce spending. These innovative technologies may represent our best hope for dealing with the challenges – primarily due to an ageing population – that lie ahead.